Venture Capital Archives - Page 48 of 111 - Boston Life Sciences Times

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

March 13, 2026

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

THIS WEEK'S STORIES

Cambridge Startup Axiomatic AI Raises $18M to Build Verified AI Platform for Engineering

March 9, 2026

UK Biotech Firm Abselion Opens U.S. Subsidiary in Cambridge Innovation Hub

March 9, 2026

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

March 10, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Cambridge Startup Axiomatic AI Raises $18M to Build Verified AI Platform for Engineering

Cognito Therapeutics Raises $105 Million Series C to Advance Alzheimer’s Therapy Platform

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

BreezeBio Raises $60 Million in Series B to Advance Precision Genetic Medicines Pipeline

Synthpop Raises $15 Million Series A to Expand AI Platform for Healthcare Workflow Automation

Most Read

KORU Medical Systems Secures EU MDR Certification for Freedom60 Infusion Pump With Prefilled Syringe Compatibility

OpenFold Consortium Releases Major OpenFold3 Update and Public Training Data for Biomolecular AI

Allurion Appeals NYSE Delisting Decision as It Pursues Plan to Regain Listing Compliance

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

EDITOR PICKS

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

THIS WEEK'S STORIES

Cambridge Startup Axiomatic AI Raises $18M to Build Verified AI Platform for Engineering

UK Biotech Firm Abselion Opens U.S. Subsidiary in Cambridge Innovation Hub

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

POPULAR CATEGORY

ABOUT US

FOLLOW US